全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Transcriptional Changes in Schistosoma mansoni during Early Schistosomula Development and in the Presence of Erythrocytes

DOI: 10.1371/journal.pntd.0000600

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Schistosomes cause more mortality and morbidity than any other human helminth, but control primarily relies on a single drug that kills adult worms. The newly transformed schistosomulum stage is susceptible to the immune response and is a target for vaccine development and rational drug design. Methodology/Principal Findings To identify genes which are up-regulated during the maturation of Schistosoma mansoni schistosomula in vitro, we cultured newly transformed parasites for 3 h or 5 days with and without erythrocytes and compared their transcriptional profiles using cDNA microarrays. The most apparent changes were in the up-regulation of genes between 3 h and 5 day schistosomula involved in blood feeding, tegument and cytoskeletal development, cell adhesion, and stress responses. The most highly up-regulated genes included a tegument tetraspanin Sm-tsp-3 (1,600-fold up-regulation), a protein kinase, a novel serine protease and serine protease inhibitor, and intestinal proteases belonging to distinct mechanistic classes. The inclusion of erythrocytes in the culture medium resulted in a general but less pronounced increase in transcriptional activity, with the highest up-regulation of genes involved in iron metabolism, proteolysis, and transport of fatty acids and sugars. Conclusions We have identified the genes that are up-regulated during the first 5 days of schistosomula development in vitro. Using a combination of gene silencing techniques and murine protection studies, some of these highly up-regulated transcripts can be targeted for future development of new vaccines and drugs.

References

[1]  Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21: 659–667. doi: 10.1097/QCO.0b013e328318978f
[2]  Loukas A, Tran M, Pearson MS (2007) Schistosome membrane proteins as vaccines. Int J Parasitol 37: 257–263. doi: 10.1016/j.ijpara.2006.12.001
[3]  McManus DP, Loukas A (2008) Current status of vaccines for Schistosomaisis. Clinical Review of Microbiology 21: 225–242. doi: 10.1128/cmr.00046-07
[4]  Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460: 352–358. doi: 10.1038/nature08160
[5]  Braschi S, Borges WC, Wilson RA (2006) Proteomic analysis of the schistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz 101: Suppl 1205–212. doi: 10.1590/S0074-02762006000900032
[6]  Braschi S, Wilson RA (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347–356. doi: 10.1074/mcp.M500287-MCP200
[7]  Perez-Sanchez R, Ramajo-Hernandez A, Ramajo-Martin V, Oleaga A (2006) Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics 6: Suppl 1S226–236. doi: 10.1002/pmic.200500420
[8]  van Balkom BW, van Gestel RA, Brouwers JF, Krijgsveld J, Tielens AG, et al. (2005) Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J Proteome Res 4: 958–966. doi: 10.1021/pr050036w
[9]  DeMarco R, Verjovski-Almeida S (2009) Schistosomes–proteomics studies for potential novel vaccines and drug targets. Drug Discov Today 14: 472–478. doi: 10.1016/j.drudis.2009.01.011
[10]  Gobert GN, McManus DP, Nawaratna S, Moertel L, Mulvenna J, et al. (2009) Tissue Specific Profiling of Females of Schistosoma japonicum by Integrated Laser Microdissection Microscopy and Microarray Analysis. PLoS Negl Trop Dis 3: e469. doi: 10.1371/journal.pntd.0000469
[11]  Kalinna BH, Brindley PJ (2007) Manipulating the manipulators: advances in parasitic helminth transgenesis and RNAi. Trends Parasitol 23: 197–204. doi: 10.1016/j.pt.2007.03.007
[12]  Mountford AP, Harrop R, Wilson RA (1995) Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immun 63: 1980–1986.
[13]  Coulson PS (1997) The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol 39: 271–336. doi: 10.1016/S0065-308X(08)60048-2
[14]  El Ridi R, Tallima H (2009) Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. Vaccine 27: 666–673. doi: 10.1016/j.vaccine.2008.11.039
[15]  Payares G, McLaren DJ, Evans WH, Smithers SR (1985) Changes in the surface antigen profile of Schistosoma mansoni during maturation from cercaria to adult worm. Parasitology 91(Pt 1): 83–99. doi: 10.1017/S0031182000056535
[16]  Simpson AJ, Payares G, Walker T, Knight M, Smithers SR (1984) The modulation of expression of polypeptide surface antigens on developing schistosomula of Schistosoma mansoni. J Immunol 133: 2725–2730.
[17]  Payares G, McLaren DJ, Evans WH, Smithers SR (1985) Antigenicity and immunogenicity of the tegumental outer membrane of adult Schistosoma mansoni. Parasite Immunol 7: 45–61. doi: 10.1111/j.1365-3024.1985.tb00478.x
[18]  Clegg JA, Smithers SR, Terry RJ (1971) Acquisition of human antigens by Schistosoma mansoni during cultivation in vitro. Nature 232: 653–654. doi: 10.1038/232653a0
[19]  Kemp WM, Merritt SC, Bogucki MS, Rosier JG, Seed JR (1977) Evidence for adsorption of heterospecific host immunoglobulin on the tegument of Schistosoma mansoni. J Immunol 119: 1849–1854.
[20]  Sher A, Hall BF, Vadas MA (1978) Acquisition of murine major histocompatibility complex gene products by schistosomula of Schistosoma mansoni. J Exp Med 148: 46–57. doi: 10.1084/jem.148.1.46
[21]  Basch PF (1981) Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing. J Parasitol 67: 179–185. doi: 10.2307/3280632
[22]  Goldring OL, Clegg JA, Smithers SR, Terry RJ (1976) Acquisition of human blood group antigens by Schistosoma mansoni. Clin Exp Immunol 26: 181–187.
[23]  Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, et al. (2008) Schistosoma mansoni Tegument Protein Sm29 Is Able to Induce a Th1-Type of Immune Response and Protection against Parasite Infection. PLoS Negl Trop Dis 2: e308. doi: 10.1371/journal.pntd.0000308
[24]  Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective vaccine antigens in mice and Sm-TSP-2 is selectively recognized by naturally resistant individuals. Nature Medicine 12: 835–840.
[25]  Dillon GP, Feltwell T, Skelton JP, Ashton PD, Coulson PS, et al. (2006) Microarray analysis identifies genes preferentially expressed in the lung schistosomulum of Schistosoma mansoni. Int J Parasitol 36: 1–8. doi: 10.1016/j.ijpara.2005.10.008
[26]  James ER, Taylor MG (1976) Transformation of cercariae to schistosomula: a quantitative comparison of transformation techniques and of infectivity by different injection routes of the organisms produced. J Helminthol 50: 223–233. doi: 10.1017/S0022149X0002664X
[27]  Lazdins JK, Stein MJ, David JR, Sher A (1982) Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of Percoll. Exp Parasitol 53: 39–44. doi: 10.1016/0014-4894(82)90090-X
[28]  Correnti JM, Brindley PJ, Pearce EJ (2005) Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol 143: 209–215. doi: 10.1016/j.molbiopara.2005.06.007
[29]  Bustin SA, Dorudi S (2004) Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Expert Rev Mol Diagn 4: 599–607. doi: 10.1586/14737159.4.5.599
[30]  Gobert GN, Moertel L, Brindley PJ, McManus DP (2009) Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics 10: 128. doi: 10.1186/1471-2164-10-128
[31]  Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, et al. (2006) Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project. Nat Biotechnol 24: 1140–1150. doi: 10.1038/nbt1242
[32]  Zhou Y, Zheng H, Liu F, Hu W, Wang ZQ, et al. (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460: 345–351. doi: 10.1038/nature08140
[33]  Emanuelsson O, Brunak S, von Heijne G, Nielsen H (2007) Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2: 953–971. doi: 10.1038/nprot.2007.131
[34]  Verjovski-Almeida S, DeMarco R, Martins EA, Guimaraes PE, Ojopi EP, et al. (2003) Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet 35: 148–157. doi: 10.1038/ng1237
[35]  Morey JS, Ryan JC, Van Dolah FM (2006) Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 8: 175–193. doi: 10.1251/bpo126
[36]  Zhou Z, Hu X, Huang Y, Hu H, Ma C, et al. (2007) Molecular cloning and identification of a novel Clonorchis sinensis gene encoding a tegumental protein. Parasitol Res 101: 737–742. doi: 10.1007/s00436-007-0541-8
[37]  Mountford AP, Harrop R (1998) Vaccination against Schistosomiasis: The case for Lung-stage Antigens. Parasitol Today 14: 109–114. doi: 10.1016/S0169-4758(97)01169-1
[38]  Wilson RA, Coulson PS (2009) Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol 25: 423–431. doi: 10.1016/j.pt.2009.05.011
[39]  Pearce EJ, MacDonald AS (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499–511. doi: 10.1038/nri843
[40]  Moqbel R, Macdonald AJ, Cromwell O, Kay AB (1990) Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni. Immunology 69: 435–442.
[41]  Jolly ER, Chin CS, Miller S, Bahgat MM, Lim KC, et al. (2007) Gene expression patterns during adaptation of a helminth parasite to different environmental niches. Genome Biol 8: R65. doi: 10.1186/gb-2007-8-4-r65
[42]  Gobert GN, Stenzel DJ, McManus DP, Jones MK (2003) The ultrastructural architecture of the adult Schistosoma japonicum tegument. Int J Parasitol 33: 1561–1575. doi: 10.1016/S0020-7519(03)00255-8
[43]  Jones MK, Gobert GN, Zhang L, Sunderland P, McManus DP (2004) The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays 26: 752–765. doi: 10.1002/bies.20058
[44]  Wright MD, Henkle KJ, Mitchell GF (1990) An immunogenic Mr 23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen. J Immunol 144: 3195–3200.
[45]  Lin YL, He S (2006) Sm22.6 antigen is an inhibitor to human thrombin. Mol Biochem Parasitol 147: 95–100. doi: 10.1016/j.molbiopara.2006.01.012
[46]  Pacifico LG, Fonseca CT, Chiari L, Oliveira SC (2006) Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology 211: 97–104. doi: 10.1016/j.imbio.2005.06.004
[47]  Fitzsimmons CM, Stewart TJ, Hoffmann KF, Grogan JL, Yazdanbakhsh M, et al. (2004) Human IgE response to the Schistosoma haematobium 22.6 kDa antigen. Parasite Immunol 26: 371–376. doi: 10.1111/j.0141-9838.2004.00721.x
[48]  Salter JP, Choe Y, Albrecht H, Franklin C, Lim KC, et al. (2002) Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes. J Biol Chem 277: 24618–24624. doi: 10.1074/jbc.M202364200
[49]  McKerrow JH, Pino-Heiss S, Lindquist R, Werb Z (1985) Purification and characterization of an elastinolytic proteinase secreted by cercariae of Schistosoma mansoni. J Biol Chem 260: 3703–3707.
[50]  Newport GR, McKerrow JH, Hedstrom R, Petitt M, McGarrigle L, et al. (1988) Cloning of the proteinase that facilitates infection by schistosome parasites. J Biol Chem 263: 13179–13184.
[51]  Kawamoto T, Noshiro M, Shen M, Nakamasu K, Hashimoto K, et al. (1998) Structural and phylogenetic analyses of RGD-CAP/beta ig-h3, a fasciclin-like adhesion protein expressed in chick chondrocytes. Biochim Biophys Acta 1395: 288–292. doi: 10.1016/S0167-4781(97)00172-3
[52]  Kasschau MR, Robinson DC, Dreden MH (1986) Schistosoma mansoni: activation of hemolytic activity in homogenates from live adult worms. Exp Parasitol 62: 442–449. doi: 10.1016/0014-4894(86)90053-6
[53]  Don TA, Bethony JM, Loukas A (2008) Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections. International Journal of Infectious Diseases. doi: 10.1016/j.ijid.2007.10.007
[54]  Skelly PJ, Kim JW, Cunningham J, Shoemaker CB (1994) Cloning, characterization, and functional expression of cDNAs encoding glucose transporter proteins from the human parasite Schistosoma mansoni. J Biol Chem 269: 4247–4253.
[55]  Caffrey CR, McKerrow JH, Salter JP, Sajid M (2004) Blood ‘n’ guts: an update on schistosome digestive peptidases. Trends Parasitol 20: 241–248. doi: 10.1016/j.pt.2004.03.004
[56]  Morales ME, Rinaldi G, Gobert GN, Kines KJ, Tort JF, et al. (2008) RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade. Mol Biochem Parasitol 157: 160–168. doi: 10.1016/j.molbiopara.2007.10.009
[57]  You H, Zhang W, Moertel L, McManus DP, Gobert GN (2009) Transcriptional profiles of adult male and female Schistosoma japonicum in response to insulin reveal increased expression of genes involved in growth and development. Int J Parasitol. doi: 10.1016/j.ijpara.2009.06.006
[58]  Gobert GN, Stenzel DJ, Jones MK, McManus DP (1997) Immunolocalization of the fatty acid-binding protein Sj-FABPc within adult Schistosoma japonicum. Parasitology 115: 33–39. doi: 10.1017/S0031182097008925
[59]  Moertel L, McManus DP, Piva TJ, Young L, McInnes RL, et al. (2006) Oligonucleotide microarray analysis of strain- and gender-associated gene expression in the human blood fluke, Schistosoma japonicum. Mol Cell Probes 20: 280–289. doi: 10.1016/j.mcp.2006.02.002
[60]  Jang-Lee J, Curwen RS, Ashton PD, Tissot B, Mathieson W, et al. (2007) Glycomics analysis of Schistosoma mansoni egg and cercarial secretions. Mol Cell Proteomics 6: 1485–1499. doi: 10.1074/mcp.M700004-MCP200
[61]  Forrester SG, Warfel PW, Pearce EJ (2004) Tegumental expression of a novel type II receptor serine/threonine kinase (SmRK2) in Schistosoma mansoni. Mol Biochem Parasitol 136: 149–156. doi: 10.1016/j.molbiopara.2004.03.007
[62]  Aragon AD, Imani RA, Blackburn VR, Cunningham C (2008) Microarray based analysis of temperature and oxidative stress induced messenger RNA in Schistosoma mansoni. Mol Biochem Parasitol 162: 134–141. doi: 10.1016/j.molbiopara.2008.08.004
[63]  Gobert GN (1998) The Role of Microscopy in the Investigation of Paramyosin as a Vaccine Candidate against Schistosoma japonicum. Parasitol Today 14: 115–118. doi: 10.1016/S0169-4758(97)01205-2
[64]  Loukas A, Jones MK, King LT, Brindley PJ, McManus DP (2001) Receptor for Fc on the surfaces of schistosomes. Infect Immun 69: 3646–3651. doi: 10.1128/IAI.69.6.3646-3651.2001
[65]  Deng J, Gold D, LoVerde PT, Fishelson Z (2003) Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infect Immun 71: 6402–6410. doi: 10.1128/IAI.71.11.6402-6410.2003
[66]  Correa-Oliveira R, Caldas IR, Gazzinelli G (2000) Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today 16: 397–399. doi: 10.1016/S0169-4758(00)01740-3
[67]  Peck CA, Carpenter MD, Mahmoud AA (1983) Species-related innate resistance to Schistosoma mansoni. Role of mononuclear phagocytes in schistosomula killing in vitro. J Clin Invest 71: 66–72. doi: 10.1172/JCI110752

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133